CytoImmune Therapeutics, Inc. — Form D
CytoImmune Therapeutics, Inc. of Monrovia, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-06. The offering totals $100.3M, of which $36.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-08-06
- Form: D
- Accession: 0001876708-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.3M
- Amount sold: $36.5M
- Remaining: $63.8M
- Investors: 4
- Date of first sale: 2021-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-409127
Issuer
- Name: CytoImmune Therapeutics, Inc.
- CIK: 0001876708
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1218 S 5th Ave, Monrovia, CA, 91016
- Phone: 4692222350
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Kinam T Hong | Director | Monrovia, CA |
| Douglas T Williams | Director | Monrovia, CA |
| Aleksey Krylov | Executive Officer | Monrovia, CA |
| Will Rosellini | Executive Officer | New York, NY |
| Richard T Santulli | Executive Officer | Monrovia, CA |
More